These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 439107)

  • 1. Cytotoxicity in progressive systemic sclerosis: no evidence for increased cytotoxicity against fibroblasts of different origin.
    Cooper SM; Friou GJ
    J Rheumatol; 1979; 6(1):25-9. PubMed ID: 439107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis.
    Penning CA; Cunningham J; French MA; Harrison G; Rowell NR; Hughes P
    Clin Exp Immunol; 1984 Sep; 57(3):548-56. PubMed ID: 6467679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
    Kondo H; Rabin BS; Rodnan GP
    J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
    Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
    Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective decrease in antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus and progressive systemic sclerosis.
    Cooper SM; Harding B; Mirick GR; Schneider J; Quismorio FP; Friou GJ
    Clin Exp Immunol; 1978 Nov; 34(2):235-40. PubMed ID: 737908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum-induced enhancement of peripheral blood mononuclear cell-mediated cytotoxicity towards human target cells in systemic sclerosis.
    Penning CA; Wright JK; Ashby JC; Cunningham J; Rowell NR; Hughes P
    J Clin Lab Immunol; 1983 Oct; 12(2):77-81. PubMed ID: 6644792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-dependent and phytohaemagglutinin-induced lymphocyte cytotoxicity in systemic sclerosis.
    Wright JK; Hughes P; Rowell NR; Sneddon IB
    Clin Exp Immunol; 1979 Apr; 36(1):175-82. PubMed ID: 466860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
    Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
    Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
    Kawaguchi Y; Harigai M; Hara M; Fukasawa C; Takagi K; Tanaka M; Tanaka E; Nishimagi E; Kamatani N
    J Rheumatol; 2002 Sep; 29(9):1877-83. PubMed ID: 12233882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts.
    Fineschi S; Cozzi F; Burger D; Dayer JM; Meroni PL; Chizzolini C
    Rheumatology (Oxford); 2007 Dec; 46(12):1779-85. PubMed ID: 17982166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunobiology of systemic sclerosis.
    Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
    Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of cytotoxic reactivity to cultured normal skin fibroblasts in sera from normal and sarcoma-bearing patients.
    Catapano MS; Brown JM; Rosenberg SA
    Cancer Res; 1980 Apr; 40(4):979-83. PubMed ID: 6928402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular IL-1 receptor antagonist is elevated in human dermal fibroblasts that overexpress intracellular precursor IL-1 alpha.
    Higgins GC; Wu Y; Postlethwaite AE
    J Immunol; 1999 Oct; 163(7):3969-75. PubMed ID: 10490999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sera from patients with scleroderma inhibit fibroblast micromotions monitored electrically.
    Huang CN; Lo CM; Hsu TC; Tsay GJ
    J Rheumatol; 1999 Jun; 26(6):1312-7. PubMed ID: 10381049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody to gp50, a glycoprotein shared in common between fibroblasts and lymphocytes, in progressive systemic sclerosis.
    Alderuccio F; Witherden D; Toh BH; Barnett A
    Clin Exp Immunol; 1989 Oct; 78(1):26-30. PubMed ID: 2805420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis.
    Stuart JM; Postlethwaite AE; Kang AH
    J Lab Clin Med; 1976 Oct; 88(4):601-7. PubMed ID: 965811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of the mechanism of disorders of the natural killer cell activity in patients with systemic scleroderma].
    Rudnicka L; Majewski S; Błaszczyk M; Skiendzielewska A; Makieła B
    Przegl Dermatol; 1990; 77(4):252-4. PubMed ID: 2267353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of the scleroderma phenotype in fibroblasts from systemic sclerosis patients.
    Qi Q; Guo Q; Tan G; Mao Y; Tang H; Zhou C; Zeng F
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):160-8. PubMed ID: 19054252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.